Sanofi's Ansan plant to move in Handok Eumsung plant.

Published: 2006-05-26 06:56:00

Updated: 2006-05-26 06:56:00

Sanofi-Aventis Korea announced that the Ansan plant would shut down and move up to the Handok's Eumsung plant after the company merger between Sanofi-Synthelabo and Aventis in 2004 under the production optimizing strategy instructed by the head office.

Handok is an outstanding Korean listed dr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK